Churg-Strauss syndrome: Difference between revisions

(Churg-Strauss syndrome)
 
Line 6: Line 6:


==Clinical Features==
==Clinical Features==
*Classically develops in three sequential phases
*Classically develops in three sequential phases:
 
*#Prodrome
*Prodrome
*#*Atopic diseases, allergic rhinitis, and asthma
**Atopic diseases, allergic rhinitis, and asthma
*#Eosinophilic phase
 
*#*Multiorgan involvement, particularly lung and GI tract
*Eosinophilic phase
*#*Caused by eosinophilic infiltration into these organs
**Multiorgan involvement, particularly lung and GI tract
*#Vasculitic phase  
**Caused by eosinophilic infiltration into these organs
*#*Life threatening vasculitis associated with vascular and extravascular granulomatosis
 
*#*May present with nonspecific signs such as fever, weight loss, malaise
*Vasculitic phase  
**Life threatening vasculitis associated with vascular and extravascular granulomatosis
**May present with nonspecific signs such as fever, weight loss, malaise


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 11:18, 7 February 2016

Background

  • Eosinophilic granulomatosis with polyangiitis (EGPA)
  • Chronic sinusitis, asthma, and peripheral eosinophilia
  • Vasculitis of small and medium sized vessels
  • Lung and skin are most commonly involved

Clinical Features

  • Classically develops in three sequential phases:
    1. Prodrome
      • Atopic diseases, allergic rhinitis, and asthma
    2. Eosinophilic phase
      • Multiorgan involvement, particularly lung and GI tract
      • Caused by eosinophilic infiltration into these organs
    3. Vasculitic phase
      • Life threatening vasculitis associated with vascular and extravascular granulomatosis
      • May present with nonspecific signs such as fever, weight loss, malaise

Differential Diagnosis

  • Aspirin-exacerbated respiratory disease
  • Chronic eosinophilic pneumonia
  • Allergic bronchopulmonary aspergillosis
  • Hypereosinophilic syndrome
  • Other vasculitides

Diagnosis

  • Typically a clinical diagnosis
  • Labs with elevated eosinophils, ESR, CRP, ANCA
  • CXR with transient, patchy opacities

Management

  • Initiation Therapy
    • Prednisone 0.5-1.5 mg/kg/day
    • Cyclophosphamide
  • Maintenance Therapy
    • Azathioprine
    • Methotrexate
    • Leflunomide
    • Inhaled glucocorticoids

Disposition

  • Refer to rheumatology

See Also

External Links

References

<UpToDate>